drugset / Trial / NCT06847178

Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes

NCT06847178 ↗

Phase 2/3 Not yet recruiting 60 enrolled Shanghai Changzheng Hospital
RandomizedSequentialTriple-blindTreatment

Summary

This trial is conducted in China. The aim of the trial is to investigate the efficacy and safety of an Bamboo cane polysaccharide (oral LC-Z300-01) in subjects with type 2 diabetes.

Timeline

Start
2025-03-01
Primary completion
2025-10-31
Completion
2025-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject LC-Z300-01 Unknown — Oral